| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -295.96M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 2617.HK returned -81.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -91.0% |
| 1 year | -81.2% |
| All-time high | $200.60 (Nov 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 2617.HK would be worth today ›No. TransThera Sciences (Nanjing), Inc. has not paid a dividend in the past 12 months.
TransThera Sciences (Nanjing), Inc. is part of the Healthcare sector.
TransThera Sciences (Nanjing), Inc. has a market cap of 4.06B HKD, based on the latest quote.
